Karyopharm Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.77

-0.32 (-3.12%)

As of Jun 30, 10:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +403.0% upside

Low Target $31.72

Average Target $49.14

High Target $61.64

Current Price $9.77

Current
$9.77

Target
$49.14

$31.72 $49.14 avg $61.64

Scenario Analysis

Bear Case

$31.72

224.7%

Low target

Base Case

$49.14

+403.0%

Avg target

Bull Case

$61.64

+530.9%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$10.99

-11.1% from high

52-Week Low

$3.65

+167.6% from low

Target vs 52W High

$49.14

+347.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%